These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29956379)

  • 1. Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta-analysis.
    Hosseini-Moghaddam SM; Krishnan RJ; Guo H; Kumar D
    Clin Transplant; 2018 Aug; 32(8):e13339. PubMed ID: 29956379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Permpalung N; Kittipibul V; Mekraksakit P; Rattanawong P; Nematollahi S; Zhang SX; Steinke SM
    Transplantation; 2021 Oct; 105(10):2291-2306. PubMed ID: 33323766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
    Cheng B; Qi C; Zhang S; Wang X
    Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
    Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
    Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Nagpal AD; Jevnikar AM
    Clin Transplant; 2021 Jul; 35(7):e14322. PubMed ID: 33882151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.
    Radisic M; Lattes R; Chapman JF; del Carmen Rial M; Guardia O; Seu F; Gutierrez P; Goldberg J; Casadei DH
    Transpl Infect Dis; 2003 Jun; 5(2):84-93. PubMed ID: 12974789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
    Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
    BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
    Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.
    Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY
    Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.
    Arend SM; Westendorp RG; Kroon FP; van't Wout JW; Vandenbroucke JP; van Es LA; van der Woude FJ
    Clin Infect Dis; 1996 Jun; 22(6):920-5. PubMed ID: 8783687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
    Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
    Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
    Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
    Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Fishman JA; Gans H;
    Clin Transplant; 2019 Sep; 33(9):e13587. PubMed ID: 31077616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
    Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
    Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.